Skip to main content

March 2024

 

 

academics

 

Clinical research courses

Applications are invited for the Post of Research Scientist at Central University of Punjab

The Central University of Punjab, has been established in 2009 along with other new Central Universities by an Act of Parliament (No 25, of 2009). Central University has completed a remarkable journey of 12 years. University is accredited ‘A’ grade in 2016 in first accreditation cycle by NAAC and has secured 95th, 87th and 84th rank in the year 2019, 2020 and 2021 respectively in the University category of NIRF. It is credited with highest per capita research funding.

Project Staff under CSIR/externally funded Projects tenable at IITR

The Indian Institute of Toxicology Research (IITR), established in 1965, a constituent laboratory of Council of Scientific & Industrial Research (CSIR) engaged in the Research & Development in the areas of Environmental Toxicology, Predictive Toxicology, Health Risk Assessment, Preventive Toxicology, Inhalation Toxicology, Analytical Toxicology, and also National S&T Missions. IITR has two campuses; the main campus is located at the centre of Lucknow City and the other campus at a distance of approx. 20 km from the main campus. 

Zydus Lifesciences Walk in Drive for M.Pharm, B.Pharm, MSc in Quality Department

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for a walk-in interview for Quality Department for Zydus Biologics (Zydus Biotech Park).

Alembic Pharmaceuticals Hiring Area Manager, Zonal Manager, Regional Manager

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Post : Area Manager, Zonal Manager, Regional Manager

Sun Pharma Interview for M.Pharm, MSc in QA, QC

Sun Pharmaceutical Industries Limited is taking this opportunity to balance employment and the medications to the world. We are hereby inviting candidates who are interested to join India's No. 1 company in Pharmaceutical sector.

Walk in Drive for B.Pharm, MSc, BSc in QC, IPQA Department at Dr. Reddy Laboratories

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.

Walk In Drive for Quality Control at CTX Lifesciences, M.Pharm, B.Pharm, MSc Apply

CTX Lifesciences Pvt. Ltd., based out of Surat (Gujarat, India), is a vertically integrated API and intermediate manufacturing company established in the year of 2004. It is as a part of a privately held group worth USD 600 million called Colourtex Industries Pvt Ltd which is established since 1967 by the founder Jayantibhai Jariwala. Colourtex, today has became one of the largest dyestuff manufacturer with comprehensive range of dyes and performance chemicals for every fiber.

Walk-In Drive for Quality Control

AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). The acquisition marks a major step forward in AstraZeneca delivering on its ambition to transform cancer treatment and outcomes for patients by replacing traditional regimens like chemotherapy and radiotherapy with more targeted treatments.

Steroid drugs used for HRT can combat E. coli and MRSA

The emergence of drug-resistant bacteria is a global threat to human health, and the development of new antibiotics from scratch is an extremely expensive and time-consuming process. To address this urgent issue, researchers from Kent’s School of Biosciences have combined computational and microbiology laboratory approaches to identify existing drugs that can be repurposed to combat antibiotic-resistant bacterial infections.

FDA Approves First Gene Therapy for Children with Metachromatic Leukodystrophy

The U.S. Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or early symptomatic early juvenile metachromatic leukodystrophy (MLD).